Unknown

Dataset Information

Risk of respiratory depression with opioids and concomitant gabapentinoids.


ABSTRACT:

Introduction

The combination of opioids and central nervous system depressants such as benzodiazepines and barbiturates has an additive effect on the frequency of oversedation and respiratory depression requiring naloxone use in hospitalized patients. Gabapentinoids (gabapentin and pregabalin) are frequently prescribed with opioids for their opioid-sparing and adjuvant analgesic effects. There is limited literature on the risk of respiratory depression due to the combination of opioids and gabapentinoids requiring naloxone administration.

Methods

This retrospective study evaluated patients who were prescribed opioids and at least one dose of naloxone between March 1, 2014 and September 30, 2016. The primary objective of this study was to compare the frequency of respiratory

SUBMITTER: Savelloni J 

PROVIDER: S-EPMC5691933 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature